My Diabetes Coach, a Mobile App-Based Interactive Conversational Agent to Support Type 2 Diabetes Self-Management: Randomized Effectiveness-Implementation Trial
Enying Gong, Shaira Baptista, Anthony Russell, Paul Scuffham, Michaela Riddell, Jane Speight, Dominique Bird, Emily Williams, Mojtaba Lotfaliany, Brian Oldenburg
Journal of Medical Internet Research | JMIR PUBLICATIONS, INC | Published : 2020
BACKGROUND: Delivering self-management support to people with type 2 diabetes mellitus is essential to reduce the health system burden and to empower people with the skills, knowledge, and confidence needed to take an active role in managing their own health. OBJECTIVE: This study aims to evaluate the adoption, use, and effectiveness of the My Diabetes Coach (MDC) program, an app-based interactive embodied conversational agent, Laura, designed to support diabetes self-management in the home setting over 12 months. METHODS: This randomized controlled trial evaluated both the implementation and effectiveness of the MDC program. Adults with type 2 diabetes in Australia were recruited and random..View full abstract
Awarded by National Health and Medical Research Council (NHMRC) Partnership Grant
Awarded by NHMRC Centre of Research Excellence in Digital Technology to Transform Chronic Disease Outcomes
This research was supported by a National Health and Medical Research Council (NHMRC) Partnership Grant (ID1057411), with additional financial and in-kind support provided by Diabetes Australia, Diabetes Queensland, Diabetes Victoria, Diabetes WA, and Roche Diabetes Care. Development of the MDC app was made possible with generous financial and other support from Bupa Australia and the Bupa Foundation and collaboration with Clevertar. EG is supported by the Melbourne Graduate Research Scholarship. JS is supported by core funding from the Australian Centre for Behavioural Research in Diabetes provided by the collaboration between Diabetes Victoria and Deakin University. EG, PS, and BO are supported by the NHMRC Centre of Research Excellence in Digital Technology to Transform Chronic Disease Outcomes (ID 1170937).